Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia

Journal of Pediatrics

Volumn 166, Issue 6, 2015, Pages 1377-1384.e3

  Kusters, D Meeike ^a   Caceres, Maria ^b   Coll, Mauricio ^c   Cuffie, Cynthia ^b   Gagné, Claude ^d   Jacobson, Marc S ^e   Kwiterovich, Peter O ^f   Lee, Raymond ^b   Lowe, Robert S ^b   Massaad, Rachid ^g   McCrindle, Brian W ^h   Musliner, Thomas A ^b   Triscari, Joseph ^b   Kastelein, John J P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Almirante Colón Medical Center   (Colombia)

^d La Clinique des Maladies Lipidiques de Quebec   (Canada)

^e Department of Endocrinology ProHealth Care Associates   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MSD Belgium   (Belgium)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; AZETIDINE DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT;

ABDOMINAL PAIN; AGE; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; NONFAMILIAL HYPERCHOLESTEROLEMIA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEINURIA; PRURIGO; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TIME TO MAXIMUM PLASMA CONCENTRATION; URTICARIA; VOMITING; CLINICAL TRIAL; GENETICS; HETEROZYGOTE; HYPERCHOLESTEROLEMIA; TREATMENT OUTCOME;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHILD; DOUBLE-BLIND METHOD; FEMALE; HETEROZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84930180268     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.02.043     Document Type: Article

References (42)

1. B.W. McCrindle Familial hypercholesterolemia in children and adolescents Curr Opin Lipidol 23 2012 525 531
2. D. Marks, M. Thorogood, H.A. Neil, and S.E. Humphries A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia Atherosclerosis 168 2003 1 14
3. S.R. Daniels, and F.R. Greer Lipid screening and cardiovascular health in childhood Pediatrics 122 2008 198 208
4. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report Pediatrics 128 Suppl 5 2011 S213 S256
5. S.R. Daniels, S.S. Gidding, and S.D. de Ferranti Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 2011 S30 S37
6. Z. Reiner, A.L. Catapano, G. De Backer, I Graham, MR Taskinen, and O Wiklund ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
7. B.A. Phan, T.D. Dayspring, and P.P. Toth Ezetimibe therapy: mechanism of action and clinical update Vasc Health Risk Manag 8 2012 415 427
8. C. Gagne, D. Gaudet, and E. Bruckert Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia Circulation 105 2002 2469 2475
9. E. Stein, S. Stender, P. Mata, P Sager, D Ponsonnet, and L Melani Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin Am Heart J 148 2004 447 455
10. J.J. Kastelein, F. Akdim, E.S. Stroes, A.H. Zwinderman, M.L. Bots, and A.F. Stalenhoef Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 2008 1431 1443
11. A. van der Graaf, C. Cuffie-Jackson, M.N. Vissers, M.D. Trip, C Gagné, and G Shi Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia J Am Coll Cardiol 52 2008 1421 1429
12. P.P. Toth, A. Catapano, J.E. Tomassini, and A.M. Tershakovec Update on the efficacy and safety of combination ezetimibe plus statin therapy Clin Lipidol 5 2010 655 684
13. D. Yeste, P. Chacon, M. Clemente, M.A. Albisu, M. Gussinye, and A. Carrascosa Ezetimibe as monotherapy in the treatment of hypercholesterolemia in children and adolescents J Pediatr Endocrinol Metab 22 2009 487 492
14. M.B. Araujo, P.M. Botto, and C.S. Mazza Use of ezetimibe in the treatment of familial hypercholesterolemia in children and adolescents An Pediatr (Barc) 77 2012 37 42
15. S. Clauss, K.M. Wai, R.E. Kavey, and K. Kuehl Ezetimibe treatment of pediatric patients with hypercholesterolemia J Pediatr 154 2009 869 872
16. S.S. Gidding, B.A. Dennison, L.L. Birch, S.R. Daniels, M.W. Gillman, and A.H. Lichtenstein Dietary recommendations for children and adolescents: a guide for practitioners Pediatrics 117 2006 544 559
17. K.Y. Liang, and S.L. Zeger Longitudinal data analysis of continuous and discrete responses for pre-post designs Sankhya Ser B 62 2000 134 148
18. O. Miettinen, and M. Nurminen Comparative analysis of two rates Stat Med 4 1985 213 226
19. A. Elis, R. Zhou, and E.A. Stein Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades Cardiol Young 24 2014 437 441
20. T. Kosoglou, T. Kakkar, P. Statkevich, L Anderson, S Pai, and T Boutros Multiple-dose safety and pharmacokinetics of ezetimibe in adolescent children (abstr) Clin Pharmacol Ther 69 2001 P52
21. T. Kosoglou, P. Statkevich, A.O. Johnson-Levonas, J.F. Paolini, A.J. Bergman, and K.B. Alton Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions Clin Pharmacokinet 44 2005 467 494
22. A. Pandor, R.M. Ara, I. Tumur, A.J. Wilkinson, S. Paisley, and A. Duenas Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials J Intern Med 265 2009 568 580
23. C.M. Ballantyne, J. Houri, A. Notarbartolo, L. Melani, L.J. Lipka, and R. Suresh Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial Circulation 107 2003 2409 2415
24. A.C. Goldberg, A. Sapre, J. Liu, R. Capece, and Y.B. Mitchel Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial Mayo Clin Proc 79 2004 620 629
25. S. Conard, H. Bays, L.A. Leiter, S. Bird, J. Lin, and M.E. Hanson Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither Diabetes Obes Metab 12 2010 210 218
26. M. Denke, T. Pearson, P. McBride, R.A. Gazzara, W.E. Brady, and A.M. Tershakovec Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome Diab Vasc Dis Res 3 2006 93 102
27. L.A. Leiter, D.J. Betteridge, M. Farnier, J.R. Guyton, J. Lin, and A. Shah Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials Diabetes Obes Metab 13 2011 615 628
28. L. Simons, M. Tonkon, L. Masana, D. Maccubbin, A. Shah, and M. Lee Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome Curr Med Res Opin 20 2004 1437 1445
29. M. Farnier, M. Volpe, R. Massaad, M.J. Davies, and C. Allen Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease Int J Cardiol 102 2005 327 332
30. L.A. Leiter, H. Bays, S. Conard, S. Bird, J. Rubino, and M.E. Hanson Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease Am J Cardiol 102 2008 1495 1501
31. E.A. Stein, L. Ose, K. Retterstol, S. Tonstatd, M. Schleman, and S. Harris Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterotemia J Clin Lipidol 1 2007 280 286
32. I. Hamilton-Craig, K. Kostner, D. Colquhoun, and S. Woodhouse Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia Vasc Health Risk Manag 6 2010 1023 1037
33. A.S. Wierzbicki, E. Doherty, P.J. Lumb, G. Chik, and M.A. Crook Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias Curr Med Res Opin 21 2005 333 338
34. D. Steinberg The rationale for initiating treatment of hypercholesterolemia in young adulthood Curr Atheroscler Rep 15 2013 296
35. A. Vuorio, K.F. Docherty, S.E. Humphries, J. Kuoppala, and P.T. Kovanen Statin treatment of children with familial hypercholesterolemia - trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus? Atherosclerosis 226 2013 315 320
36. A.C. Goldberg, P.N. Hopkins, P.P. Toth, C.M. Ballantyne, D.J. Rader, and J.G. Robinson Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 2011 133 140
37. D.M. Kusters, C. De Beaufort, K. Widhalm, K. Widhalm, O. Guardamagna, and N. Bratina Paediatric screening for hypercholesterolaemia in Europe Arch Dis Child 97 2012 272 276
38. P.O. Kwiterovich, and S.S. Gidding Universal screening of cholesterol in children Clin Cardiol 35 2012 662 664
39. B.G. Nordestgaard, M.J. Chapman, S.E. Humphries, H.N. Ginsberg, L. Masana, and O.S. Descamps Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society Eur Heart J 34 2013 3478 3490a
40. H.J. Avis, B.A. Hutten, C. Gagne, G. Langlet, B.W. McCrindle, and A. Weigman Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia J Am Coll Cardiol 55 2010 1121 1126
41. B.W. McCrindle, L. Ose, and A.D. Marais Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial J Pediatr 142 2003 74 80
42. A. Wiegman, B.A. Hutten, E. de Groot, J. Rodenburg, H.D. Bakker, and H.R. Buller Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial JAMA 292 2004 331 337